Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 609

1.

Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.

Chekaoui A, Belguendouz H, Lahmar K, Mazari F, Terahi M, Hakem D, Youinou P, Touil-Boukoffa C.

Int Immunopharmacol. 2020 Jan 9;80:106119. doi: 10.1016/j.intimp.2019.106119. [Epub ahead of print]

PMID:
31927504
2.

Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.

Chekaoui A, Lahmar K, Belguendouz H, Mazari F, Terahi M, Hakem D, Youinou P, Touil-Boukoffa C.

Eur Cytokine Netw. 2018 Sep 1;29(3):95-102. doi: 10.1684/ecn.2018.0411.

PMID:
30547891
3.

Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.

Benchabane S, Belkhelfa M, Belguendouz H, Zidi S, Boudjelida A, Youinou P, Touil-Boukoffa C.

Inflammopharmacology. 2018 Oct;26(5):1165-1174. doi: 10.1007/s10787-018-0499-4. Epub 2018 Jun 4.

PMID:
29869303
4.

Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.

Benchabane S, Belguendouz H, Behairi N, Arroul-Lammali A, Boudjelida A, Youinou P, Touil-Boukoffa C.

Immunopharmacol Immunotoxicol. 2018 Apr;40(2):126-133. doi: 10.1080/08923973.2017.1418881. Epub 2018 Jan 5.

PMID:
29303022
5.

Human regulatory B cells control the TFH cell response.

Achour A, Simon Q, Mohr A, Séité JF, Youinou P, Bendaoud B, Ghedira I, Pers JO, Jamin C.

J Allergy Clin Immunol. 2017 Jul;140(1):215-222. doi: 10.1016/j.jaci.2016.09.042. Epub 2016 Nov 16.

PMID:
27865860
6.

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

Garaud S, Taher TE, Debant M, Burgos M, Melayah S, Berthou C, Parikh K, Pers JO, Luque-Paz D, Chiocchia G, Peppelenbosch M, Isenberg DA, Youinou P, Mignen O, Renaudineau Y, Mageed RA.

Cell Mol Immunol. 2018 Feb;15(2):158-170. doi: 10.1038/cmi.2016.42. Epub 2016 Aug 8.

7.

A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Benchabane S, Boudjelida A, Toumi R, Belguendouz H, Youinou P, Touil-Boukoffa C.

Int J Immunopathol Pharmacol. 2016 Sep;29(3):386-97. doi: 10.1177/0394632016651273. Epub 2016 May 19.

8.

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.

Seret G, Cañas F, Pougnet-Di Costanzo L, Hanrotel-Saliou C, Jousse-Joulin S, Le Meur Y, Saraux A, Valeri A, Putterman C, Youinou P, Rojas-Villarraga A, Anaya JM, Renaudineau Y.

J Autoimmun. 2015 Jul;61:54-61. doi: 10.1016/j.jaut.2015.05.009. Epub 2015 Jun 10.

PMID:
26071203
9.

Cytokines Modulate the "Immune-Metabolism" Interactions during Behçet Disease: Effect on Arginine Metabolism.

Belguendouz H, Lahmar-Belguendouz K, Messaoudene D, Djeraba Z, Otmani F, Hakem D, Lahlou-Boukoffa OS, Youinou P, Touil-Boukoffa C.

Int J Inflam. 2015;2015:241738. doi: 10.1155/2015/241738. Epub 2015 Jan 27.

10.

Primary Sjögren's syndrome at a glance today.

Youinou P, Pers JO.

Joint Bone Spine. 2015 Mar;82(2):75-6. doi: 10.1016/j.jbspin.2014.10.018. Epub 2015 Jan 22. No abstract available.

PMID:
25619154
11.

Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival.

Lahiri A, Varin MM, Le Pottier L, Pochard P, Bendaoud B, Youinou P, Pers JO.

J Autoimmun. 2014 Jun;51:30-7. doi: 10.1016/j.jaut.2014.02.004. Epub 2014 Mar 3.

PMID:
24602383
12.

TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.

Guerrier T, Pochard P, Lahiri A, Youinou P, Pers JO, Jamin C.

J Autoimmun. 2014 Jun;51:23-9. doi: 10.1016/j.jaut.2014.02.005. Epub 2014 Feb 26.

PMID:
24582318
13.

Diagnostic criteria for autoimmune neutropenia.

Youinou P, Jamin C, Le Pottier L, Renaudineau Y, Hillion S, Pers JO.

Autoimmun Rev. 2014 Apr-May;13(4-5):574-6. doi: 10.1016/j.autrev.2014.01.001. Epub 2014 Jan 11. Review.

PMID:
24418296
14.

Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.

Séïté JF, Goutsmedt C, Youinou P, Pers JO, Hillion S.

J Allergy Clin Immunol. 2014 Jan;133(1):181-8.e1-9. doi: 10.1016/j.jaci.2013.08.042. Epub 2013 Oct 17. Review.

PMID:
24139609
15.

DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.

Fali T, Le Dantec C, Thabet Y, Jousse S, Hanrotel C, Youinou P, Brooks WH, Perl A, Renaudineau Y.

Autoimmunity. 2014 Jun;47(4):265-71. doi: 10.3109/08916934.2013.826207. Epub 2013 Oct 14.

16.

Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.

Tobón GJ, Saraux A, Gottenberg JE, Quartuccio L, Fabris M, Seror R, Devauchelle-Pensec V, Morel J, Rist S, Mariette X, De Vita S, Youinou P, Pers JO.

Arthritis Rheum. 2013 Dec;65(12):3218-27. doi: 10.1002/art.38129.

17.

[Regulatory lymphocytes: a new cooperation between T and B cells for a better control of the immune response].

Jamin C, Achour A, Youinou P, Pers JO.

Presse Med. 2014 Jan;43(1):18-26. doi: 10.1016/j.lpm.2013.02.332. Epub 2013 Jul 18. Review. French.

PMID:
23871608
18.

Are the B cells cast with the leading part in the Sjogren's syndrome scenario?

Pers JO, Youinou P.

Oral Dis. 2014 Sep;20(6):529-37. doi: 10.1111/odi.12153. Epub 2013 Jul 10. Review.

PMID:
23837848
19.

Importance of Toll-like receptors for B lymphocyte survival in primary Sjögren's syndrome.

Guerrier T, Le Pottier L, Youinou P, Pers JO, Jamin C.

Bull Group Int Rech Sci Stomatol Odontol. 2013 Jul 10;52(1):e1-6.

PMID:
25461443
20.

Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria?

Cornec D, Jousse-Joulin S, Pers JO, Marhadour T, Cochener B, Boisramé-Gastrin S, Nowak E, Youinou P, Saraux A, Devauchelle-Pensec V.

Arthritis Rheum. 2013 Jan;65(1):216-25. doi: 10.1002/art.37698.

21.

Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden.

Shapira Y, Agmon-Levin N, Renaudineau Y, Porat-Katz BS, Barzilai O, Ram M, Youinou P, Shoenfeld Y.

Exp Mol Pathol. 2012 Dec;93(3):386-90. doi: 10.1016/j.yexmp.2012.09.012. Epub 2012 Sep 25.

PMID:
23022373
22.

B lymphocytes in nonorgan-specific autoimmune diseases: implications for therapy.

Youinou P, Pers JO.

Lupus. 2012 Nov;21(13):1375-7. doi: 10.1177/0961203312460901. Epub 2012 Sep 12. No abstract available.

PMID:
22976931
23.

Regulatory B cells play a key role in immune system balance.

Berthelot JM, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P.

Joint Bone Spine. 2013 Jan;80(1):18-22. doi: 10.1016/j.jbspin.2012.04.010. Epub 2012 Jul 31. Review.

PMID:
22858147
24.

Latest update on the primary Sjögren's syndrome.

Youinou P, Pers JO.

Presse Med. 2012 Sep;41(9 Pt 2):e437-9. doi: 10.1016/j.lpm.2012.05.020. Epub 2012 Jul 31. No abstract available.

PMID:
22857888
25.

Pathophysiological cytokine network in primary Sjögren's syndrome.

Pers JO, Lahiri A, Tobón GJ, Youinou P.

Presse Med. 2012 Sep;41(9 Pt 2):e467-74. doi: 10.1016/j.lpm.2012.04.029. Epub 2012 Jul 24. Review.

PMID:
22836197
26.

Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome.

Agmon-Levin N, Kivity S, Tzioufas AG, López Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P, Shoenfeld Y.

J Autoimmun. 2012 Sep;39(3):234-9. doi: 10.1016/j.jaut.2012.05.018. Epub 2012 Jul 24.

PMID:
22835660
27.

The complexity of the BAFF TNF-family members: implications for autoimmunity.

Lahiri A, Pochard P, Le Pottier L, Tobón GJ, Bendaoud B, Youinou P, Pers JO.

J Autoimmun. 2012 Sep;39(3):189-98. doi: 10.1016/j.jaut.2012.05.009. Epub 2012 Jun 29. Review.

PMID:
22749832
28.

Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link?

Thabet Y, Cañas F, Ghedira I, Youinou P, Mageed RA, Renaudineau Y.

J Autoimmun. 2012 Sep;39(3):154-60. doi: 10.1016/j.jaut.2012.05.015. Epub 2012 Jun 16. Review.

PMID:
22709855
29.

TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity.

Guerrier T, Youinou P, Pers JO, Jamin C.

J Autoimmun. 2012 Sep;39(3):173-9. doi: 10.1016/j.jaut.2012.05.012. Epub 2012 Jun 12.

PMID:
22695187
30.

The miscellany of anti-endothelial cell autoantibodies.

Youinou P, Jamin C.

Isr Med Assoc J. 2012 Feb;14(2):119-20. No abstract available.

31.

Neurological Disorders in Primary Sjögren's Syndrome.

Tobón GJ, Pers JO, Devauchelle-Pensec V, Youinou P.

Autoimmune Dis. 2012;2012:645967. doi: 10.1155/2012/645967. Epub 2012 Mar 5.

32.

Role of Toll-like receptors in primary Sjögren's syndrome with a special emphasis on B-cell maturation within exocrine tissues.

Guerrier T, Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P.

J Autoimmun. 2012 Aug;39(1-2):69-76. doi: 10.1016/j.jaut.2012.01.016. Epub 2012 Feb 21.

PMID:
22357449
33.

CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte.

Mageed RA, Garaud S, Taher TE, Parikh K, Pers JO, Jamin C, Renaudineau Y, Youinou P.

Autoimmun Rev. 2012 Sep;11(11):795-8. doi: 10.1016/j.autrev.2012.02.007. Epub 2012 Feb 12. Review.

PMID:
22349614
34.

Epigenetics and Sjögren's syndrome.

Le Dantec C, Varin MM, Brooks WH, Pers JO, Youinou P, Renaudineau Y.

Curr Pharm Biotechnol. 2012 Aug;13(10):2046-53. Review.

35.

B-lymphocytes govern the pathogenesis of Sjögren's syndrome.

Youinou P, Saraux A, Pers JO.

Curr Pharm Biotechnol. 2012 Aug;13(10):2071-7. Review.

PMID:
22208653
36.

Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis.

Seret G, Le Meur Y, Renaudineau Y, Youinou P.

Clin Dev Immunol. 2012;2012:579670. doi: 10.1155/2012/579670. Epub 2011 Nov 28. Review.

37.

Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease.

Messaoudene D, Belguendouz H, Ahmedi ML, Benabdekader T, Otmani F, Terahi M, Youinou P, Touil-Boukoffa C.

J Inflamm (Lond). 2011 Nov 21;8:35. doi: 10.1186/1476-9255-8-35.

38.

Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy.

Cornec D, Tempescul A, Querellou S, Hutin P, Pers JO, Jamin C, Bendaoud B, Berthou C, Renaudineau Y, Youinou P.

Ann Hematol. 2012 May;91(5):715-721. doi: 10.1007/s00277-011-1369-y. Epub 2011 Nov 16.

PMID:
22083514
39.

Maturation and function of human dendritic cells are regulated by B lymphocytes.

Morva A, Lemoine S, Achour A, Pers JO, Youinou P, Jamin C.

Blood. 2012 Jan 5;119(1):106-14. doi: 10.1182/blood-2011-06-360768. Epub 2011 Nov 8.

PMID:
22067387
40.

Membrane microdomain sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells.

Hammadi M, Youinou P, Tempescul A, Tobón G, Berthou C, Bordron A, Pers JO.

Haematologica. 2012 Feb;97(2):288-96. doi: 10.3324/haematol.2011.051938. Epub 2011 Nov 4.

41.

Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1.

Zachou K, Oikonomou K, Renaudineau Y, Chauveau A, Gatselis N, Youinou P, Dalekos GN.

Aliment Pharmacol Ther. 2012 Jan;35(1):116-25. doi: 10.1111/j.1365-2036.2011.04908.x. Epub 2011 Nov 2.

42.

In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation.

Varin MM, Guerrier T, Devauchelle-Pensec V, Jamin C, Youinou P, Pers JO.

Autoimmun Rev. 2012 Feb;11(4):252-8. doi: 10.1016/j.autrev.2011.10.005. Epub 2011 Oct 7. Review.

PMID:
22001522
43.

Are autoimmune diseases predictable?

Tobón GJ, Pers JO, Cañas CA, Rojas-Villarraga A, Youinou P, Anaya JM.

Autoimmun Rev. 2012 Feb;11(4):259-66. doi: 10.1016/j.autrev.2011.10.004. Epub 2011 Oct 7. Review.

PMID:
22001417
44.

Epigenetic alterations and autoimmune disease.

Renaudineau Y, Beauvillard D, Padelli M, Brooks WH, Youinou P.

J Dev Orig Health Dis. 2011 Oct;2(5):258-64. doi: 10.1017/S2040174411000353.

PMID:
25141262
45.

Disturbance of cytokine networks in Sjögren's syndrome.

Youinou P, Pers JO.

Arthritis Res Ther. 2011 Jul 6;13(4):227. doi: 10.1186/ar3348. Review.

46.

TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.

Séité JF, Guerrier T, Cornec D, Jamin C, Youinou P, Hillion S.

J Autoimmun. 2011 Nov;37(3):190-7. doi: 10.1016/j.jaut.2011.05.014.

PMID:
21689906
47.

DNA methylation and B-cell autoreactivity.

Garaud S, Youinou P, Renaudineau Y.

Adv Exp Med Biol. 2011;711:50-60. Review.

PMID:
21627042
48.

Diagnostic accuracy of ACR/EULAR 2010 criteria for rheumatoid arthritis in a 2-year cohort.

Varache S, Cornec D, Morvan J, Devauchelle-Pensec V, Berthelot JM, Le Henaff-Bourhis C, Hoang S, Thorel JB, Martin A, Chalès G, Nowak E, Jousse-Joulin S, Youinou P, Saraux A.

J Rheumatol. 2011 Jul;38(7):1250-7. doi: 10.3899/jrheum.101227. Epub 2011 May 15.

PMID:
21572146
49.

Epigenetics and autoimmunity, with special emphasis on methylation.

Renaudineau Y, Youinou P.

Keio J Med. 2011;60(1):10-6. Review.

50.

CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.

Garaud S, Morva A, Lemoine S, Hillion S, Bordron A, Pers JO, Berthou C, Mageed RA, Renaudineau Y, Youinou P.

J Immunol. 2011 Apr 15;186(8):4835-44. doi: 10.4049/jimmunol.1003050. Epub 2011 Mar 11.

Supplemental Content

Loading ...
Support Center